AMCP Praises FDA’s Guidance on Communications Between Biopharmaceutical Companies and Population Health Decision Makers

Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the Food and Drug Administration (FDA) for its release today of draft guidance clarifying how biopharmaceutical companies and population health decision makers can proactively share clinical and economic information on both FDA approved products as well as emerging therapies awaiting FDA approval.